These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 31986407)
1. Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m Zhu B; Gong Y; Shen L; Li J; Han J; Song B; Hu L; Wang Q; Wang Z Biomed Pharmacother; 2020 Apr; 124():109935. PubMed ID: 31986407 [TBL] [Abstract][Full Text] [Related]
2. Total Panax notoginseng saponin inhibits balloon injury-induced neointimal hyperplasia in rat carotid artery models by suppressing pERK/p38 MAPK pathways. Yang Z; Zhang H; An M; Bian M; Song M; Guo X; Liu Q; Qiu M Braz J Med Biol Res; 2020; 53(1):e9085. PubMed ID: 31859914 [TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway. Huang R; Huang Y; Zeng G; Li M; Jin Y Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193 [TBL] [Abstract][Full Text] [Related]
4. Effects and mechanisms of total Panax notoginseng saponins on proliferation of vascular smooth muscle cells with plasma pharmacology method. Zhang W; Chen G; Deng CQ J Pharm Pharmacol; 2012 Jan; 64(1):139-45. PubMed ID: 22150681 [TBL] [Abstract][Full Text] [Related]
5. Dioscin inhibits intimal hyperplasia in rat carotid artery balloon injury model through inhibition of the MAPK-FoxM1 pathway. Fan T; He J; Yin Y; Wen K; Kang Y; Zhao H; Chen S; Li X Eur J Pharmacol; 2019 Jul; 854():213-223. PubMed ID: 30940448 [TBL] [Abstract][Full Text] [Related]
6. Effect of total saponins of "panax notoginseng root" on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats. Wu L; Zhang W; Tang YH; Li H; Chen BY; Zhang GM; Deng CQ Phytomedicine; 2010 Mar; 17(3-4):233-40. PubMed ID: 19748258 [TBL] [Abstract][Full Text] [Related]
7. Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats. Zhang YQ; Tian F; Zhou Y; Chen YD; Li B; Ma Q; Zhang Y Cardiovasc Diabetol; 2016 Apr; 15():62. PubMed ID: 27059601 [TBL] [Abstract][Full Text] [Related]
8. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARĪ± pathway. Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859 [TBL] [Abstract][Full Text] [Related]
9. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress. Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743 [TBL] [Abstract][Full Text] [Related]
10. Yang GS; Zheng B; Qin Y; Zhou J; Yang Z; Zhang XH; Zhao HY; Yang HJ; Wen JK Theranostics; 2020; 10(17):7787-7811. PubMed ID: 32685020 [No Abstract] [Full Text] [Related]
11. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling. Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126 [TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway. Li X; Du JR; Yu Y; Bai B; Zheng XY J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression. Zhu B; Gong Y; Yan G; Wang D; Wang Q; Qiao Y; Hou J; Liu B; Tang C FEBS J; 2017 Jun; 284(12):1868-1881. PubMed ID: 28425161 [TBL] [Abstract][Full Text] [Related]
14. Nkx2-3 induces autophagy inhibiting proliferation and migration of vascular smooth muscle cells via AMPK/mTOR signaling pathway. Zheng H; Zhai W; Zhong C; Hong Q; Li H; Rui B; Zhu X; Que D; Feng L; Yu B; Huang G; Yin J; Li J; Yan J; Yang P J Cell Physiol; 2021 Nov; 236(11):7342-7355. PubMed ID: 33928642 [TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCĪ±-mediated MKP-1 induction. Kim SY; Kwon YW; Jung IL; Sung JH; Park SG Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882 [TBL] [Abstract][Full Text] [Related]
16. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691 [TBL] [Abstract][Full Text] [Related]
17. [Effect of Panax notoginseng saponins on vascular intima hyperplasia and PCNA expression in rat aorta after balloon angioplasty]. Wang J; Wu L; Zhang W; Deng C Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):735-9. PubMed ID: 19624018 [TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement attenuates intimal hyperplasia development in an androgen deficient model of vascular injury. Freeman BM; Univers J; Fisher RK; Kirkpatrick SS; Klein FA; Freeman MB; Mountain DJ; Grandas OH J Surg Res; 2017 Jan; 207():53-62. PubMed ID: 27979488 [TBL] [Abstract][Full Text] [Related]
19. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury. Helkin A; Bruch D; Wilson DR; Gruessner AC; Bader RR; Maier KG; Gahtan V Vasc Endovascular Surg; 2019 Jul; 53(5):379-386. PubMed ID: 30982448 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of polycomb repressor complex 2 ameliorates neointimal hyperplasia by suppressing trimethylation of H3K27 in vascular smooth muscle cells. Liang J; Li Q; Cai W; Zhang X; Yang B; Li X; Jiang S; Tian S; Zhang K; Song H; Ai D; Zhang X; Wang C; Zhu Y Br J Pharmacol; 2019 Sep; 176(17):3206-3219. PubMed ID: 31162630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]